Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population
- PMID: 33754278
- PMCID: PMC8458476
- DOI: 10.1007/s10689-021-00243-3
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population
Abstract
Lynch syndrome (LS) is the most common inherited cause of colorectal and endometrial cancers. Identifying individuals at risk for LS without personal cancer history requires detailed collection and assessment of family health history. However, barriers exist to family health history collection, especially in historically underserved populations. To improve LS risk assessment in historically underserved populations, we adapted the provider-facing PREdiction Model for gene Mutations (PREMM5™ model), a validated LS risk assessment model, into a patient-facing electronic application through an iterative development process involving expert and patient stakeholders. We report on preliminary findings based on the first 500 individuals exposed to the adapted application in a primary care population enriched for low-literacy and low-resource patients. Major adaptations to the PREMM5™ provider module included reduction in reading level, addition of interactive literacy aids, incorporation of family history assessment for both maternal and paternal sides of the family, and inclusion of questions about individual relatives or small groups of relatives to reduce cognitive burden. In the first 500 individuals, 90% completed the PREMM5™ independently; of those, 94% did so in 5 min or less (ranged from 0.2 to 48.8 min). The patient-facing application was able to accurately classify 84% of patients as having clinically significant or not clinically significant LS risk. Our preliminary results suggest that in this diverse study population, most participants were able to rapidly, accurately, and independently complete an interactive application collecting family health history assessment that accurately assessed for Lynch syndrome risk.
Keywords: Family history; Hereditary cancer; Lynch syndrome; Risk assessment; Underserved.
© 2021. The Author(s).
Conflict of interest statement
PREMM® and all associated logos are trademarks™ or registered® trademarks of Dana Farber Cancer Institute, Inc. Dr. Syngal has served as a consultant for Myriad Genetics and DC Health Technologies, and has rights to an inventor portion of the licensing revenue from PREMM®5.
All other authors report no conflict of interest.
Figures
Similar articles
-
Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing.J Clin Oncol. 2020 Dec 1;38(34):4086-4094. doi: 10.1200/JCO.20.01470. Epub 2020 Sep 30. J Clin Oncol. 2020. PMID: 32997573 Free PMC article.
-
Use and feasibility of a Lynch Syndrome predictive model for inherited colorectal and endometrial cancer in a low-middle income country.Fam Cancer. 2024 Nov;23(4):563-567. doi: 10.1007/s10689-024-00422-y. Epub 2024 Sep 24. Fam Cancer. 2024. PMID: 39317871
-
Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome.J Clin Oncol. 2017 Jul 1;35(19):2165-2172. doi: 10.1200/JCO.2016.69.6120. Epub 2017 May 10. J Clin Oncol. 2017. PMID: 28489507 Free PMC article.
-
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.Health Technol Assess. 2017 Sep;21(51):1-238. doi: 10.3310/hta21510. Health Technol Assess. 2017. PMID: 28895526 Free PMC article. Review.
-
Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer.Adv Anat Pathol. 2017 Nov;24(6):372-378. doi: 10.1097/PAP.0000000000000169. Adv Anat Pathol. 2017. PMID: 28820751 Free PMC article. Review.
Cited by
-
Usability, Engagement, and Report Usefulness of Chatbot-Based Family Health History Data Collection: Mixed Methods Analysis.J Med Internet Res. 2024 Sep 30;26:e55164. doi: 10.2196/55164. J Med Internet Res. 2024. PMID: 39348188 Free PMC article.
-
Hereditary Cancer Genetic Testing: 30 Years of Impact on Cancer Care.Dela J Public Health. 2024 Aug 28;10(3):16-20. doi: 10.32481/djph.2024.08.06. eCollection 2024 Aug. Dela J Public Health. 2024. PMID: 39211401 Free PMC article. No abstract available.
-
Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study.Cancer Med. 2023 Sep;12(18):19112-19125. doi: 10.1002/cam4.6485. Epub 2023 Aug 30. Cancer Med. 2023. PMID: 37644850 Free PMC article.
-
Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project.J Community Genet. 2023 Jun;14(3):329-336. doi: 10.1007/s12687-023-00647-x. Epub 2023 May 1. J Community Genet. 2023. PMID: 37126135 Free PMC article.
-
Medical interpreter-mediated genetic counseling for Spanish preferring adults at risk for a hereditary cancer syndrome.J Genet Couns. 2023 Aug;32(4):870-886. doi: 10.1002/jgc4.1695. Epub 2023 Mar 20. J Genet Couns. 2023. PMID: 36938783 Free PMC article.
References
-
- Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338(21):1481–1487. doi: 10.1056/NEJM199805213382101. - DOI - PubMed
-
- Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26(35):5783–5788. doi: 10.1200/JCO.2008.17.5950. - DOI - PMC - PubMed
-
- Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A, Consortium E. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012;308(15):1555–1565. doi: 10.1001/jama.2012.13088. - DOI - PMC - PubMed
-
- Yurgelun MB, Kulke MH, Fuchs CS, Allen BA, Uno H, Hornick JL, Ukaegbu CI, Brais LK, McNamara PG, Mayer RJ, Schrag D, Meyerhardt JA, Ng K, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Syngal S. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol. 2017;35(10):1086–1095. doi: 10.1200/JCO.2016.71.0012. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
